Recent Quotes (30 days)

You have no recent quotes
chg | %

Life Science Developments Ltd news

   Watch this stock
Showing stories 1 - 10 of about 71   

Articles published

LIFE 3.17 +0.30 (10.43%)
price chart
Callum McCaig: Living in tough times
Only two years ago �14.8bn was invested in new and existing developments. That investment will ... Tourism, life sciences and food and drink will play a major part in that process, as will our renowned strength as a centre for excellence as an oil and ...
I Contain Multitudes by Ed Yong review – full of life's little surprises
From this treasure-trove of research Yong pulls story after story: how luminescent bacteria colonise and control the development of light-emitting organs in the Hawaiian bobtail squid; how the beewolf wasp (since long before Fleming chanced upon ...
OptiBiotix chief hails commercial progress
A York business, which develops compounds to tackle obesity, high cholesterol and diabetes, has reported widening first-half losses but its chief executive has hailed a period of "significant progress" that included deals with two multinationals ...
Hanover reappoints Daniel Gilbert after BIS special adviser role
Gilbert (pictured) had been working as special adviser to Jo Johnson MP, the minister of state for universities and science, helping shape government policy development and communications in the higher education, science and innovation and space ...
Some "Goldilocks" Planets May Be Too Hot-Blooded for Life
... of 'regulation,' but it's an interesting paper," David Stevenson, a planetary scientist at the California Institute of Technology who was not involved in the new study, told Space.
An L�chran collaborative hub opens in Inverness
Its development is led by HIE to support the further expansion of some of the region's key sectors with a particular focus on life sciences. The site has been specifically designed to encourage collaboration between business, research and academia ...
5 top blunders life science startups make on the road to clinical trials
A classic mistake is mistrusting or not believing that data from early-development and preclinical studies is relevant to designing clinical trials.
Cryoport to Support World-Leading Life Science Company's Custom Development ...
Cryoport is the premier provider of cryogenic logistics solutions to the life sciences industry through its purpose-built proprietary packaging, information technology and specialized cold chain logistics expertise.
Regulatory Officers
With a 175 year UK manufacturing heritage, Actavis UK Ltd has grown rapidly to become a leading supplier of generic pharmaceuticals across the country.
Medicines Discovery Catapult appoints CEO
Chris Molloy, who has more than 25 years' experience in the international life science industry, will lead the MDC in developing new approaches for the discovery and early development of new medicines. Currently CEO at the RSA Group, Chris has ...